Nalbuphine/Naloxone

纳布啡/纳洛酮

Report date: 2025/05/26 17:52:27

Base Information

Drug NameNalbuphine/Naloxone
Drug Alias NameNaloxone+Nalbuphine纳洛酮/纳布啡纳洛酮+纳布啡Nalbuphine+Naloxone纳布啡+纳洛酮 +[7
ClassificationSmall molecules
Mechanisms of ActionOpioid receptors agonistsOpioid receptors antagonists
TargetsOpioid receptors
Therapy Area/IndicationsPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEvotec
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEvotec
Active IndicationsN/A
Inactive IndicationsPain

Other Information

ATC CodeN/A
Related LinksN/A